Development of beta-adrenergic receptor subsensitivity by antidepressants.
D000526:Alprenolol / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism* / Q000648:ultrastructure; D003891:Desipramine / Q000494:pharmacology; D004316:Doxepin / Q000494:pharmacology; D007488:Iprindole / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008861:Microsomes / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D004316:Doxepin; D007488:Iprindole; D000526:Alprenolol; D003891:Desipramine